NCT02877160View on ClinicalTrials.gov

A Study to Assess the PK of AL-794 Formulations in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

May 31, 2017

Conditions
Influenza
Interventions
DRUG

AL-794 suspension

DRUG

AL-794 tablet

Trial Locations (1)

Unknown

Hammersmith Medicines Research Ltd (HMR), London

Sponsors
All Listed Sponsors
lead

Alios Biopharma Inc.

INDUSTRY

NCT02877160 - A Study to Assess the PK of AL-794 Formulations in Healthy Subjects | Biotech Hunter | Biotech Hunter